Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Basecamp Research Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 examiners and 2 art units, indicating separate examination settings.
SAPKOTA, SURAJ is the busiest examiner, with 1 pending matter. Counsel should maintain coherent technical positions across the files while addressing each office action independently.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAPKOTA, SURAJ | 1 | 0.0% | +0.0% |
| SU-TOBON, QIWEN NMN | 1 | 66.7% | +66.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18721630 | Co-Delivery of a Gene Editor Construct and a Donor Template | SAPKOTA, SURAJ | — |
| 18705515 | Single Construct Platform for Simultaneous Delivery of Gene Editing Machinery and Nucleic Acid Cargo | SU-TOBON, QIWEN NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18705515 | Single Construct Platform for Simultaneous Delivery of Gene Editing Machinery and Nucleic Acid Cargo | SU-TOBON, QIWEN NMN | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18721630 | Co-Delivery of a Gene Editor Construct and a Donor Template | SAPKOTA, SURAJ | 1633 | §102§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18705515 | Single Construct Platform for Simultaneous Delivery of Gene Editing Machinery and Nucleic Acid Cargo | SU-TOBON, QIWEN NMN | 1636 | §102§103§112Other | Non-Final OA | — | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBasecamp Research Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Suraj Sapkota has the most, with 1 of Basecamp Research Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
